Caffeine as a neuroprotective adenosine receptor antagonist

Ann Pharmacother. 2004 Apr;38(4):717-8. doi: 10.1345/aph.1D307. Epub 2004 Feb 24.
No abstract available

MeSH terms

  • Adenosine A1 Receptor Antagonists*
  • Adenosine A2 Receptor Antagonists*
  • Alzheimer Disease / drug therapy
  • Animals
  • Caffeine / administration & dosage
  • Caffeine / pharmacology*
  • Caffeine / therapeutic use
  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Humans
  • Neuroprotective Agents / administration & dosage
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use
  • Parkinson Disease / drug therapy

Substances

  • Adenosine A1 Receptor Antagonists
  • Adenosine A2 Receptor Antagonists
  • Neuroprotective Agents
  • Caffeine